These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 18785200)

  • 1. Synthesis of anti-microtubule biaryls and preliminary evaluation as vascular-disrupting agents.
    Joncour A; Liu JM; Décor A; Thoret S; Wdzieczak-Bakala J; Bignon J; Baudoin O
    ChemMedChem; 2008 Nov; 3(11):1731-9. PubMed ID: 18785200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiangiogenic and antitumoral activity of phenyl-3-(2-chloroethyl)ureas: a class of soft alkylating agents disrupting microtubules that are unaffected by cell adhesion-mediated drug resistance.
    Petitclerc E; Deschesnes RG; Côté MF; Marquis C; Janvier R; Lacroix J; Miot-Noirault E; Legault J; Mounetou E; Madelmont JC; C -Gaudreault R
    Cancer Res; 2004 Jul; 64(13):4654-63. PubMed ID: 15231678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of C-12' substituted vinflunine derivatives.
    Lei XS; Yu XD; Yin L; Liu ZH; Tang PC
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4602-5. PubMed ID: 18653334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary biological evaluations of new thalidomide analogues for multiple sclerosis application.
    Contino-Pépin C; Parat A; Périno S; Lenoir C; Vidal M; Galons H; Karlik S; Pucci B
    Bioorg Med Chem Lett; 2009 Feb; 19(3):878-81. PubMed ID: 19103485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and structure-activity relationships of 2-amino-1-aroylnaphthalene and 2-hydroxy-1-aroylnaphthalenes as potent antitubulin agents.
    Reddy GR; Kuo CC; Tan UK; Coumar MS; Chang CY; Chiang YK; Lai MJ; Yeh JY; Wu SY; Chang JY; Liou JP; Hsieh HP
    J Med Chem; 2008 Dec; 51(24):8163-7. PubMed ID: 19053773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and structure-activity relationships of constrained heterocyclic analogues of combretastatin A4.
    Arthuis M; Pontikis R; Chabot GG; Seguin J; Quentin L; Bourg S; Morin-Allory L; Florent JC
    ChemMedChem; 2011 Sep; 6(9):1693-705. PubMed ID: 21732536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two novel series of allocolchicinoids with modified seven membered B-rings: design, synthesis, inhibition of tubulin assembly and cytotoxicity.
    Büttner F; Bergemann S; Guénard D; Gust R; Seitz G; Thoret S
    Bioorg Med Chem; 2005 May; 13(10):3497-511. PubMed ID: 15848763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
    Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
    Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New NSAIDs-NO hybrid molecules with antiproliferative properties on human prostatic cancer cell lines.
    Bézière N; Goossens L; Pommery J; Vezin H; Touati N; Hénichart JP; Pommery N
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4655-7. PubMed ID: 18667313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-(2,6-dimethoxypyridine-3-yl)-9-methylcarbazole-3-sulfonamide as a novel tubulin ligand against human cancer.
    Wang YM; Hu LX; Liu ZM; You XF; Zhang SH; Qu JR; Li ZR; Li Y; Kong WJ; He HW; Shao RG; Zhang LR; Peng ZG; Boykin DW; Jiang JD
    Clin Cancer Res; 2008 Oct; 14(19):6218-27. PubMed ID: 18829501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, and biological evaluation of the first podophyllotoxin analogues as potential vascular-disrupting agents.
    Labruère R; Gautier B; Testud M; Seguin J; Lenoir C; Desbène-Finck S; Helissey P; Garbay C; Chabot GG; Vidal M; Giorgi-Renault S
    ChemMedChem; 2010 Dec; 5(12):2016-25. PubMed ID: 20979080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and preliminary biological evaluation of new anti-tubulin agents containing different benzoheterocycles.
    Romagnoli R; Baraldi PG; Jung MK; Iaconinoto MA; Carrion MD; Remusat V; Preti D; Tabrizi MA; Francesca F; De Clercq E; Balzarini J; Hamel E
    Bioorg Med Chem Lett; 2005 Sep; 15(18):4048-52. PubMed ID: 16005627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of amide derivatives of diflunisal as potential anti-tumor agents.
    Zhong GX; Chen LL; Li HB; Liu FJ; Hu JQ; Hu WX
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4399-402. PubMed ID: 19515562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel potent antimitotic heterocyclic ketones: synthesis, antiproliferative activity, and structure-activity relationships.
    Hu L; Jiang JD; Qu J; Li Y; Jin J; Li ZR; Boykin DW
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3613-7. PubMed ID: 17482458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NPI-2358 is a tubulin-depolymerizing agent: in-vitro evidence for activity as a tumor vascular-disrupting agent.
    Nicholson B; Lloyd GK; Miller BR; Palladino MA; Kiso Y; Hayashi Y; Neuteboom ST
    Anticancer Drugs; 2006 Jan; 17(1):25-31. PubMed ID: 16317287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of aromatic enones related to curcumin.
    Robinson TP; Hubbard RB; Ehlers TJ; Arbiser JL; Goldsmith DJ; Bowen JP
    Bioorg Med Chem; 2005 Jun; 13(12):4007-13. PubMed ID: 15911313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-Phenyl-N'-(2-chloroethyl)urea analogues of combretastatin A-4: Is the N-phenyl-N'-(2-chloroethyl)urea pharmacophore mimicking the trimethoxy phenyl moiety?
    Fortin S; Moreau E; Lacroix J; Teulade JC; Patenaude A; C-Gaudreault R
    Bioorg Med Chem Lett; 2007 Apr; 17(7):2000-4. PubMed ID: 17291753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic antiangiogenic effects of stathmin inhibition and taxol exposure.
    Mistry SJ; Bank A; Atweh GF
    Mol Cancer Res; 2007 Aug; 5(8):773-82. PubMed ID: 17670914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of novel 4-(hetero) aryl-2-piperazino quinazolines as anti-leishmanial and anti-proliferative agents.
    Kumar S; Shakya N; Gupta S; Sarkar J; Sahu DP
    Bioorg Med Chem Lett; 2009 May; 19(9):2542-5. PubMed ID: 19328690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of 4-arylcoumarin analogues of combretastatins with microtubule network of HBL100 cells and binding to tubulin.
    Rappl C; Barbier P; Bourgarel-Rey V; Grégoire C; Gilli R; Carre M; Combes S; Finet JP; Peyrot V
    Biochemistry; 2006 Aug; 45(30):9210-8. PubMed ID: 16866367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.